Park Ha Biological Technology Co., Ltd. Ordinary Shares·Consumer Cyclical
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Park Ha Biological Technology Co. Ltd. (NASDAQ: BYAH) resulting from allegations that Park Ha Biological may have issued materially misleading business information to the investing public. So what: If you purchased Park Ha Biological securities you may be entitled to compensation without payment of any out of pocket fees or cos.